The Berried Clubby Molt & Moss
Menu

Open this gap in the complete research map

Named evidence gap

Which treatment doses are effective and safe for confirmed Neocaridina health agents?

A precise unanswered question is part of the source of truth. It prevents an absent study, indirect result or popular rule from becoming false certainty.

This is a current search boundary, not proof that no study exists. The dated searches below show what was checked, which candidates were included or excluded and what evidence would change the answer.

Current boundary

One three-aquarium conference abstract reported complete Deugesia removal and three-day survival of all 12 shrimp after mebendazole or albendazole additions, but it omitted aquarium volume, usable concentration, replicated vessels, explicit control results, sublethal endpoints and recurrence follow-up. No controlled efficacy-and-safety trial was located for common hobby salt, fenbendazole, praziquantel or peroxide doses against named Neocaridina health agents.

What would answer it

Confirmed-agent trials with concentration verification, exposure duration, untreated controls, life-stage safety and recurrence follow-up.

Answerability brief

Specialist-led research is required

The question requires specialist identification, analytical verification, welfare oversight or treatment authority beyond an ordinary keeper observation.

Decision at stake: Whether a confirmed agent can be treated at a verified exposure while preserving shrimp welfare across life stages.

Primary endpoint: Confirmed agent clearance and recurrence, paired with survival, behavior, molting and reproduction safety endpoints.

Minimum design: Specialist-confirmed agent trials with untreated and vehicle controls, verified concentration and exposure, independently replicated systems, life-stage safety and prespecified rescue or stopping rules.

Required reporting: Agent identification and confirmation method, product and active ingredient, formulation, measured concentration, water chemistry, exposure and withdrawal, allocation, independent units, complete agent and animal denominators, adverse events, recurrence and professional oversight.

Community can contribute: Clear images, retained specimens and complete prior-treatment histories can improve agent identification and candidate-study selection through qualified channels.

Community observations cannot establish: A visual label, disappearance after dosing or survivor report cannot diagnose the agent, establish efficacy or authorize a dose.

Closure rule: A treatment claim requires confirmed-agent efficacy and shrimp safety for the exact formulation and exposure. Another organism, product or concentration does not inherit the result.

Open this question in the complete answerable research agenda.

Current research allocation

Qualified collaboration required

The current publisher cannot answer this alone. Work waits for suitable facilities, expertise, oversight and independently replicated units.

Why this allocation: Diagnosis, verified exposure, agent clearance and life-stage safety require specialist authority and cannot be crowdsourced through dosing reports.

Next permitted unit: Present the evidence gap and minimum design to an aquatic veterinarian, parasitologist or qualified disease laboratory for critique.

Activation trigger: A specialist can confirm the agent, authorize welfare safeguards and verify concentration in replicated controlled systems.

Stop decision: Do not recruit treatment trials, recommend a dose or reinterpret unconfirmed disappearance as efficacy. Keep immediate public guidance at identification and system triage.

Open this question in the complete finite research portfolio.

Reviewed: August 12, 2026.

Topics: Health, Chemical exposure

Practical guides governed by this gap

Reproducible search trail

Gap refined Reviewed August 12, 2026

Which common hobby treatments are both effective against confirmed targets and safe for Neocaridina?

Taxon names: Neocaridina davidi, Neocaridina heteropoda, Neocaridina denticulata sinensis.

Concepts: Scutariella japonica, Holtodrilus, Cladogonium, Deugesia, planaria, salt treatment, hydrogen peroxide, mebendazole, albendazole.

Search surfaces: publisher and DOI records, PubMed, scholarly web indexes, full-text repositories, multilingual university and journal repositories.

Outcome: A direct pilot abstract narrows the boundary for mebendazole and albendazole, but its incomplete dose, one-vessel-per-group design and three-day survival endpoint do not validate a treatment protocol. No controlled efficacy-and-host-safety trial for the named common hobby salt, fenbendazole, praziquantel or peroxide treatments was located. The gap remains open.

Exact queries and candidate decisions

Exact queries

  • Neocaridina davidi Scutariella japonica treatment salinity experiment
  • Neocaridina heteropoda Holtodrilus treatment salt salinity
  • Neocaridina denticulata sinensis parasite treatment efficacy salt
  • Neocaridina davidi Cladogonium treatment hydrogen peroxide experiment
  • Neocaridina antiparasitic treatment in vivo efficacy
  • Neocaridina chemotherapy ectoparasite treatment bath
  • Neocaridina planaria albendazol mebendazol experimento aquario
  • Neocaridina heteropoda mebendazol
  • Neocaridina heteropoda albendazol
  • Neocaridina traitement parasite antiparasitaire etude
  • 樱花虾 寄生虫 治疗 实验 盐 浸浴
  • 米虾 寄生虫 药物 治疗 试验

Candidate sources

Next scheduled search: February 12, 2027. Also governs: treatment-efficacy

Help close or refine this gap

Submit a stable source or correction. A title, abstract or community consensus does not close the gap until its methods and claim boundary are reviewed.